Patents by Inventor Stuart D. Shanler

Stuart D. Shanler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190167566
    Abstract: The present invention is directed to: a) a method of treating telangiectasia; b) a method of treating inflammatory lesions; and c) a method of treating two or more symptoms of rosacea selected from erythema, telangiectasia, or inflammatory lesions comprising topical administration of a pharmaceutical composition comprising oxymetazoline and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: February 5, 2019
    Publication date: June 6, 2019
    Inventors: Stuart D. SHANLER, Christopher POWALA
  • Publication number: 20190060311
    Abstract: Methods of treating vitiligo using JAK/STAT modulating compounds are provided herein. The JAK/STAT modulating compounds may be selected from 5-((2-((4-fluoro-3-methoxy-5-methylphenyl)amino)-5-methylpyrimidin-4-yl)amino)benzo[d] oxazol-2(3H)-one, disodium (5-((2-((4-fluoro-3-methoxy-5-methylphenyl)amino)-5-methylpyrimidin-4-yl)amino)-2-oxobenzo[d]oxazol-3(2H)-yl)methyl phosphate, tofacitinib, ruxolitinib, baricitinib, lestaurtinib, decernotinib, TG101348, Janex 1, PF-956980, WHI-P154, ZM-39923, NSC114792, cerdulatinib, fedratinib, PF-06263276, CEP-33779, AZD-1480, SHR0302, oclacitinib, filgotinib, gandotinib, momelotinib, pacritinib, upadacitinib, peficitinib, PF-04965842, N-(3-acetamido-5-(quinaxalin-2-yl) phenyl) acrylamide, 1-[(2S,5R)-2-Methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-2-propen-1-one malonate (PF-06651600), [(1S)-2,2-Difluorocyclopropyl][3-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-3,8-diazabicyclo[3.2.
    Type: Application
    Filed: August 23, 2018
    Publication date: February 28, 2019
    Inventors: Stuart D. SHANLER, Evan DICK, Neal Stuart WALKER, Christopher POWALA
  • Publication number: 20190046565
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Application
    Filed: October 15, 2018
    Publication date: February 14, 2019
    Inventors: Stuart D. SHANLER, Christopher POWALA, Christopher PHILLIPS, Brian BEGER, Charles Rodney GREENAWAY EVANS, Sian Tiong LIM, Marc Barry BROWN, Michael A. BOTTA, Thomas NAGLER
  • Publication number: 20190008857
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenergic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Application
    Filed: August 20, 2018
    Publication date: January 10, 2019
    Inventors: Stuart D. Shanler, Andrew Ondo
  • Publication number: 20180360827
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenengic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Application
    Filed: August 22, 2018
    Publication date: December 20, 2018
    Inventors: Stuart D. Shanler, Andrew Ondo
  • Publication number: 20180303875
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Application
    Filed: April 24, 2018
    Publication date: October 25, 2018
    Inventors: Stuart D. SHANLER, Christopher POWALA, Christopher PHILLIPS, Brian BEGER, Charles Rodney GREENAWAY EVANS, Sian Tiong LIM, Marc Barry BROWN, Michael A. BOTTA, Thomas NAGLER
  • Patent number: 10098910
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: October 16, 2018
    Assignee: ACLARIS THERAPEUTICS, INC.
    Inventors: Stuart D. Shanler, Christopher Powala, Christopher Phillips, Brian Beger, Charles Rodney Greenaway Evans, Sian Tiong Lim, Marc Barry Brown, Michael A. Botta, Thomas Nagler
  • Publication number: 20180185413
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Application
    Filed: December 21, 2017
    Publication date: July 5, 2018
    Inventors: Stuart D. SHANLER, Christopher POWALA, Christopher PHILLIPS, Brian BEGER, Charles Rodney GREENAWAY EVANS, Sian Tiong LIM, Marc Barry BROWN, Michael A. BOTTA, Thomas NAGLER
  • Patent number: 9980983
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: May 29, 2018
    Assignee: ACLARIS THERAPEUTICS, INC.
    Inventors: Stuart D. Shanler, Christopher Powala, Christopher Phillips, Brian Beger, Charles Rodney Greenaway Evans, Sian Tiong Lim, Marc Barry Brown, Michael A. Botta, Thomas Nagler
  • Publication number: 20180110805
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Application
    Filed: December 5, 2016
    Publication date: April 26, 2018
    Inventors: Stuart D. SHANLER, Christopher POWALA, Christopher PHILLIPS, Brian BEGER, Charles Rodney GREENAWAY EVANS, Sian Tiong LIM, Marc Barry BROWN, Michael A. BOTTA, Thomas NAGLER
  • Publication number: 20180050009
    Abstract: Embodiments are directed to compositions comprising greater than 40% w/w to about 70% w/w stabilized hydrogen peroxide. The composition may also include a surface tension modifying agent, such as 2-propanol. Such compositions may be used to treat conditions such as warts, condyloma accuminatum, molluscum contagiosum, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Application
    Filed: August 17, 2017
    Publication date: February 22, 2018
    Inventors: Stuart D. SHANLER, Christopher POWALA, Christopher PHILLIPS, Brian BEGER, Charles Rodney GREENAWAY EVANS, Sian Tiong LIM, Marc Barry BROWN
  • Publication number: 20180008636
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Application
    Filed: December 5, 2016
    Publication date: January 11, 2018
    Inventors: Stuart D. SHANLER, Christopher POWALA, Christopher PHILLIPS, Brian BEGER, Charles Rodney GREENAWAY EVANS, Sian Tiong LIM, Marc Barry BROWN, Michael A. BOTTA, Thomas NAGLER
  • Publication number: 20180000863
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Application
    Filed: May 10, 2017
    Publication date: January 4, 2018
    Inventors: Stuart D. SHANLER, Christopher POWALA, Christopher PHILLIPS, Brian BEGER, Charles Rodney GREENAWAY EVANS, Siang Tiong LIM, Marc Barry BROWN, Michael A. BOTTA, Thomas NAGLER
  • Publication number: 20170231985
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenergic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Application
    Filed: June 10, 2015
    Publication date: August 17, 2017
    Inventors: Stuart D. Shanler, Andrew Ondo
  • Patent number: 9675639
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: June 13, 2017
    Assignee: ACLARIS THERAPEUTICS, INC.
    Inventors: Stuart D. Shanler, Christopher Powala, Christopher Phillips, Brian Beger, Charles Rodney Greenaway Evans, Sian Tiong Lim, Marc Barry Brown, Michael A. Botta, Thomas Nagler
  • Publication number: 20160082007
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenergic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Application
    Filed: June 10, 2015
    Publication date: March 24, 2016
    Inventors: Stuart D. Shanler, Andrew Ondo
  • Patent number: 9265761
    Abstract: Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an ? adrenergic receptor agonist selected from selective ?1 adrenergic receptor agonist, selective ?2 adrenergic receptor agonist, non-selective ?1/?2 adrenergic receptor agonist, agents with ?2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.
    Type: Grant
    Filed: February 16, 2014
    Date of Patent: February 23, 2016
    Assignee: ALLERGAN, INC.
    Inventors: Stuart D. Shanler, Andrew Ondo
  • Publication number: 20150328259
    Abstract: Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
    Type: Application
    Filed: April 21, 2015
    Publication date: November 19, 2015
    Inventors: Stuart D. SHANLER, Christopher POWALA, Christopher PHILLIPS, Brian BEGER, Charles Rodney GREENAWAY EVANS, Sian Tiong LIM, Marc Barry BROWN, Michael A. BOTTA, Thomas NAGLER
  • Publication number: 20150272948
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenergic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Application
    Filed: June 10, 2015
    Publication date: October 1, 2015
    Inventors: Stuart D. Shanler, Andrew Ondo
  • Publication number: 20150045403
    Abstract: Embodiments relating to cream formulations as well as oxymetazoline creams and methods for treating rosacea and symptoms associated with rosacea, including, for example, papules, pustules, phymas (skin thickening), telangiectasias or erythema associated with rosacea, other skin erythemas, telangiectasias, purpura or the like, and other manifestations associated therewith; other inflammatory conditions of the skin including, but not limited to, keratosis pilaris, lupus miliaris dissemniatus faciei, eczema, dermatitis, such as contact dermatitis, atopic dermatitis, seborrheic dermatitis, nummular dermatitis, generalized exfoliative dermatitis, statis dermatitis, neurodermatitis, lichen simplex chronicus, xerosis and xerotic dermatitis, dyshidrosis and dyshidrotic dermatitis, asteototic dermatitis or other conditions characterized by sensitive skin or a disturbance of the epidermal barrier; disorders characterized by rough, dry, cracked or fissured skin, disorders characterized by hyperkeratotic skin such as ker
    Type: Application
    Filed: October 22, 2014
    Publication date: February 12, 2015
    Inventors: Stuart D. Shanler, Christopher Powala, Luis Rios